Robin Robinson is a contributing writer for HealthLeaders.
The drug makers are in acquisition talks, but there is no recorded offer yet and no agreement has been made public.
ASCO Chief Medical Officer evaluates the rise of the virtual model in cancer clinical trials.
Two breakthroughs in particular have the power to change survival rates.
Tune in to virtual sessions June 14–15 to learn how industry merger enforcement may change.
Sanofi and Leaps by Bayer are just two pharmaceutical companies using digital technologies to reach stakeholders more effectively.
